Latest
Hot
$Alphabet-C (GOOG.US)$/ $Alphabet-A (GOOGL.US)$'s Q1 2026 13F filing reveals a dramatic portfolio reshuffling. Holdings are highly concentrated — the top three positions account for nearly 70% of total value — with capital clearly rotating from healthcare into financial infrastructure.
Biggest Move: CME Becomes Top Holding From Zero
The standout play: $Alphabet-A (GOOGL.US)$ aggressively built a 3.48-million-share position in $CME Group (CME.US)$, worth $1...
Biggest Move: CME Becomes Top Holding From Zero
The standout play: $Alphabet-A (GOOGL.US)$ aggressively built a 3.48-million-share position in $CME Group (CME.US)$, worth $1...
+2
124
1
84
When everything starts cracking at once — $Invesco QQQ Trust (QQQ.US)$ slips, the $S&P 500 Index (.SPX.US)$ stalls, leaders like $NVIDIA (NVDA.US)$and $Tesla (TSLA.US)$break trend, and even “safe havens” like $Bitcoin (BTC.CC)$, $SPDR Gold ETF (GLD.US)$, and $iShares Silver Trust (SLV.US)$sell off — the message is clear: liquidity is leaving the room. In moments like these, investors don’t wait for confirmation. They rotate, de-risk, and hunt for whatever still ho...
+1
95
8
119
Following the wrap-up of the 4Q25 13F filings, Morgan Stanley’s latest report drops a bombshell on market expectations: despite the unstoppable global AI boom, active institutional ownership of mega-cap tech has plunged to a staggering 17-year low.
This revelation completely shatters retail stereotypes. While many assume the "smart money" is fully loaded with tech giants, the data reveals a vastly different rea...
This revelation completely shatters retail stereotypes. While many assume the "smart money" is fully loaded with tech giants, the data reveals a vastly different rea...
+3
54
7
47
Gates Foundation is out of Microsoft
The latest 13F filing for Q1 2026 shows no $Microsoft (MSFT.US)$ position, while the previous filing for Q4 2025 showed 7,691,207 Microsoft shares worth about $3.72 billion. That means the Trust sold its remaining Microsoft stake during the first quarter.
This sounds dramatic, especially because Microsoft was co-founded by Bill Gates and has long been one of the most symbolic holdings ...
The latest 13F filing for Q1 2026 shows no $Microsoft (MSFT.US)$ position, while the previous filing for Q4 2025 showed 7,691,207 Microsoft shares worth about $3.72 billion. That means the Trust sold its remaining Microsoft stake during the first quarter.
This sounds dramatic, especially because Microsoft was co-founded by Bill Gates and has long been one of the most symbolic holdings ...
42
13
36
Wall Street's latest 13F filings offer fresh insights into institutional positioning. These mandatory SEC disclosures—required from asset managers with over $100 million in U.S. equities—reveal notable moves among elite investors: Berkshire trimming Apple and BofA while debuting NYT; Bridgewater piling into Nvidia, Amazon, and Newmont; Baillie Gifford upsizing Google but downsizing Nvidia; and ARK slashing T...
33
5
10
After giving it much thought, I have made the decision to start gradually trimming my position in VOO. I never wanted to do this but I can no longer in good faith hold a position this large in the S&P 500 as valuations are now far too removed from reality. Even Buffett had sold off his position in the S&P 500 and continues to sell off his individual holdings, claiming valuations are no longer attractive and is waiting for much better opportunities. That’s a big red flag given Buffett never likes...
15
1
After the U.S. market close on February 17th, Berkshire Hathaway filed its 13F disclosure with the Securities and Exchange Commission (SEC), revealing that $Berkshire Hathaway-B (BRK.B.US)$ continued to adjust its positions in tech giants during Q4 2025. The company significantly reduced its Amazon holdings while further trimming its stakes in Apple and Bank of America, and initi...
16
1
17
$Berkshire Hathaway-B (BRK.B.US)$ Not heavily undervalued. More like **moderately undervalued to fairly valued**, with a strong downside floor.
That is the cleaner way to frame BRK.B right now.
### Short answer
* **Not “deep value” cheap**
* **Not expensive**
* **Likely modestly undervalued (roughly ~8–15%)**
* **Very strong defensive quality**
* **Low chance of permanent capital loss unless you overpay badly**
That is why BRK.B is usually a **compounder / capital-preservation stock**, not a ...
That is the cleaner way to frame BRK.B right now.
### Short answer
* **Not “deep value” cheap**
* **Not expensive**
* **Likely modestly undervalued (roughly ~8–15%)**
* **Very strong defensive quality**
* **Low chance of permanent capital loss unless you overpay badly**
That is why BRK.B is usually a **compounder / capital-preservation stock**, not a ...
7
1


72846327 : I've never liked health stocks, & the few I've tried didn't do any good . but pl . & aggressive newer stocks doing great